Search Results for: Medical uses
hamophilie-zentrum rhein main, mörfelden-walldorf, germany, vivantes klinikum im friedrichshain, berlin, germany, university of texas health science center at houston, houston, united states, university of cincinnati college of medicine and cancer and blood diseases institute, cincinnati children's hospital medical
center, cincinnati, united states, academy of medical sciences of ukraine, lviv, ukraine, baxalta us inc., a takeda company, cambridge, united states, baxalta innovations gmbh, a takeda company, vienna, austria, shire international gmbh, a takeda company, zurich, switzerland, katharine dormandy haemophilia...
https://abstracts.isth.org/abstract/personalizing-prophylaxis-with-rurioctocog-alfa-pegol-in-previously-treated-patients-with-severe-hemophilia-a-outcomes-from-the-phase-3b-continuation-and-phase-3-propel-studies/
hamophilie-zentrum rhein main, mörfelden-walldorf, germany, vivantes klinikum im friedrichshain, berlin, germany, university of texas health science center at houston, houston, united states, university of cincinnati college of medicine and cancer and blood diseases institute, cincinnati children's hospital medical
center, cincinnati, united states, academy of medical sciences of ukraine, lviv, ukraine, baxalta us inc., a takeda company, cambridge, united states, baxalta innovations gmbh, a takeda company, vienna, austria, shire international gmbh, a takeda company, zurich, switzerland, katharine dormandy haemophilia...
https://abstracts.isth.org/abstract/personalizing-prophylaxis-with-rurioctocog-alfa-pegol-in-previously-treated-patients-with-severe-hemophilia-a-outcomes-from-the-phase-3b-continuation-and-phase-3-propel-studies/